A Randomised Study Examining the Utility of Lauromacrogol Foam Sclerotherapy vs Pingyangmycin in Treatment of Pediatric Lymphatic Malformations --A Single Center Report From China

In brief

This randomized controlled trial compares two sclerosing agents—lauromacrogol foam versus pingyangmycin—for treating lymphatic malformations in pediatric patients using ultrasound guidance. The study provides evidence on treatment efficacy and safety profiles to inform clinical decision-making for managing these congenital vascular lesions in children.

Written by the GCMD Library team from the article.